1-9 of 9
Chenguang Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

GATA-3 Dependent Gene Transcription Is Impaired upon HDAC Inhibition

Xiangrong Geng, Chenguang Wang, Thilini Perera, Badeia Saed, Ying Hu, Ashley Wolfe, John C Reneau, Carlos A. Murga-Zamalloa, Ryan A. Wilcox
Journal: Blood
Blood (2023) 142 (Supplement 1): 4357.
https://doi.org/10.1182/blood-2023-172509
Published: 2023
Journal Articles

Xpo-1 Antagonism Transcriptionally Reprograms and Is a Therapeutic Vulnerability in GATA-3 Driven T-Cell Lymphomas

Chenguang Wang, Nermin Kady, Ashley Wolfe, Ira Maine, Suhaib Abdelrahman, Vanessa Perez Silos, Carlos A. Murga-Zamalloa, Ryan A. Wilcox
Journal: Blood
Blood (2023) 142 (Supplement 1): 1648.
https://doi.org/10.1182/blood-2023-187231
Published: 2023
Journal Articles

Pre-Clinical Activity of Navitoclax in TCR-Driven and Non-ALCL Mature T-Cell Lymphomas

Xiangrong Geng, Chenguang Wang, Ashley Wolfe, Ira Maine, Suhaib Abdelrahman, Carlos A. Murga-Zamalloa, Ryan A. Wilcox
Journal: Blood
Blood (2023) 142 (Supplement 1): 4146.
https://doi.org/10.1182/blood-2023-174520
Published: 2023
Journal Articles

Xpo-1 Antagonism Impairs CSF-1R Expression and Depletes Lymphoma-Associated Macrophages in T-Cell Lymphomas

Nermin Kady, Chenguang Wang, Ashley Wolfe, Ira Maine, Suhaib Abdelrahman, Carlos A. Murga-Zamalloa, Ryan A. Wilcox
Journal: Blood
Blood (2023) 142 (Supplement 1): 1647.
https://doi.org/10.1182/blood-2023-186364
Published: 2023
Journal Articles

NR4A3 Suppresses Lymphomagenesis I n Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1

Alexander JA Deutsch, PhD, Beate Rinner, Martin Pichler, Karoline Fechter, Hildegard T. Greinix, MD, Chenguang Wang, Christine Beham-Schmid, MD, Peter Neumeister, MD
Journal: Blood
Blood (2016) 128 (22): 2728.
https://doi.org/10.1182/blood.V128.22.2728.2728
Published: 2016
Journal Articles

Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)

Clinical Trials & Observations
Barbara L. Asselin, Meenakshi Devidas, Chenguang Wang, Jeanette Pullen, Michael J. Borowitz, Robert Hutchison, Steven E. Lipshultz, Bruce M. Camitta
Journal: Blood
Blood (2011) 118 (4): 874–883.
https://doi.org/10.1182/blood-2010-06-292615
Published: 2011
Journal Articles

Secondary Chromosomal Abnormalities Appear to Be Less Prognostic for Children with Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Treated with Intensified Imatinib and Chemotherapy: Results of the Children's Oncology Group (COG) Study AALL0031.

Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Meenakshi Devidas, PhD, W. Paul Bowman, Chenguang Wang, Michael Trigg, MD, Bruce Camitta, MD, Paul S. Gaynon, MD, Naomi J. Winick, MD, Stephen P Hunger, MD, William L. Carroll, MD, Kirk R. Schultz, MD
Journal: Blood
Blood (2009) 114 (22): 2606.
https://doi.org/10.1182/blood.V114.22.2606.2606
Published: 2009
Journal Articles

Philadelphia Chromosome Negative (Ph-) Very High Risk (VHR) Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents: The Impact of Intensified Chemotherapy on Early Event Free Survival (EFS) in Children’s Oncology Group (COG) Study AALL0031.

Kirk R. Schultz, MD, William Paul Bowman, William Slayton, MD, Alexander Aledo, MD, Meenakshi Devidas, PhD, Harland Sather, PhD, Michael J. Borowitz, MD, PhD, Stella M. Davies, MBBS, PhD, Michael Trigg, MD, Bernice Pasut, RN, Dean Jorstad, RPh, Tammie Eslinger, CCRP, Laura Burden, CCRP, Chenguang Wang, MS, Robert Rutledge, MD, Bruce Camitta, MD, Paul S. Gaynon, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Naomi Winick, MD, Stephen P. Hunger, MD, William L. Carroll, MD
Journal: Blood
Blood (2008) 112 (11): 911.
https://doi.org/10.1182/blood.V112.11.911.911
Published: 2008
Journal Articles

Improved Early Event Free Survival (EFS) in Children with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Intensive Imatinib in Combination with High Dose Chemotherapy: Children’s Oncology Group (COG) Study AALL0031.

Kirk R. Schultz, MD, W. Paul Bowman, MD, William Slayton, MD/PhD, Alex Aledo, MD, Meenakshi Devidas, PhD, Harland Sather, PhD, Michael J. Borowitz, MD/PhD, Stella M. Davies, MD/PhD, Michael Trigg, MD, Bernice Pasut, Dean Jorstad, Tammie Eslinger, Laura E. Burden, Chenguang Wang, PhD, Robert Rutledge, MD, Paul S. Gaynon, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Naomi Winick, MD, Stephen Hunger, MD/PhD, William L. Carroll, MD/PhD, Bruce Camitta, MD/PhD
Journal: Blood
Blood (2007) 110 (11): 4.
https://doi.org/10.1182/blood.V110.11.4.4
Published: 2007